Syneron Medical Ltd (ELOS) Reports In-Line Q2 EPS

Syneron Medical Ltd (NASDAQ: ELOS) reported Q2 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $64.6 million versus the consensus estimate of $63.52 million.

For earnings history and earnings-related data on Syneron Medical Ltd (ELOS) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Park Dental Partners, Inc. (PARK) Tops Q2 EPS by 28c
• Nortech Systems, Inc. (NSYS) Tops Q2 EPS by 11c